Last reviewed · How we verify
NCT06970444
taVNS Effect on Central Auditory Processing
NA trial testing transcutaneous auricular vagus nerve stimulation (taVNS) in Central Auditory Disease in 70 participants. Completed in 19 July 2024.
1 May 2024
Quick facts
| Lead sponsor | Medipol University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 70 |
| Start date | 1 April 2023 |
| Primary completion | 1 May 2024 |
| Estimated completion | 19 July 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- transcutaneous auricular vagus nerve stimulation (taVNS)
- Sham device — full drug profile →
Conditions studied
- Central Auditory Disease — all drugs for Central Auditory Disease →
- Auditory Processing Disorder, Central — all drugs for Auditory Processing Disorder, Central →
- Auditory Processing Disorders — all drugs for Auditory Processing Disorders →
- Vagus Nerve Stimulation — all drugs for Vagus Nerve Stimulation →
Sponsor
Medipol University
Who can join
Adults 18 to 40, any sex, with Central Auditory Disease or Auditory Processing Disorder, Central. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The behavioral effects of vagus nerve stimulation (VNS) and observed activation in the auditory cortex with transcutaneous auricular VNS (taVNS) raise questions about their potential impact on auditory processing. This study aims to investigate whether taVNS, which has not been studied in the context of central auditory processing (CAP), has any effects on CAP.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06970444
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of transcutaneous auricular vagus nerve stimulation (taVNS)
Trials testing the same drug.
- NCT07123987 — Transcutaneous Auricular Vagus Nerve Stimulation on Post-Herpetic Neuralgia · NA · recruiting
- NCT04130646 — Noninvasive VNS to Facilitate Excitability in Motor Cortex · NA · completed
Other Medipol University trials
Trials by the same sponsor.
- NCT07277803 — Device-Based vs Manual Sensory Training in Low Back Pain · NA · not yet recruiting
- NCT07214636 — Development and Investigation of the ApneaTheraPlay · NA · not yet recruiting
- NCT07534475 — Venous Tourniquet vs. Arterial Tourniquet for Seizure Monitoring in ECT · NA · not yet recruiting
- NCT07534488 — Sacral Erector Spinae Plane Block in Pilonidal Sinus Surgery · NA · not yet recruiting
- NCT07525648 — Comparison of the Effects of Sevoflurane and Desflurane on Optic Nerve Sheath Diameter During Laparoscopic Surgery · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06970444 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medipol University
- Last refreshed: 14 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06970444.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing